Lakefront Biotherapeutics American Depositary Shares
LKFT
32 hedge funds and large institutions have $367M invested in Lakefront Biotherapeutics American Depositary Shares in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 19 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
0.81% more ownership
Funds ownership: 12.57% → 13.37% (+0.81%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less funds holding
Funds holding: 44 → 32 (-12)
29% less capital invested
Capital invested by funds: $518M → $367M (-$151M)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.24M |
| 3 |
DM
Deerfield Management
New York
|
+$6.71M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.68M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.96M |
| 2 |
GP
GLG Partners
London,
United Kingdom
|
-$4.42M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.33M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$3.14M |
LKFT Hedge Fund Activity: Q1 2016 in Review
32 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q1 2016, worth a combined $367M — down 29% from $518M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of LKFT and 7 opened new positions — a net loss of 12 holders — while 8 trimmed existing stakes and 11 added.
The largest buyer was Fidelity Investments, adding an estimated $31.4M. The largest seller was Adage Capital Partners, cutting an estimated $6.96M.
- 32 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q1 2016, down from 44 in Q4 2015.
- Funds reported $367M of Lakefront Biotherapeutics American Depositary Shares stock for Q1 2016, down 29% quarter-over-quarter.
- 7 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q1 2016 and 19 closed out, a net change of -12 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q1 2016 was Fidelity Investments, an estimated $31.4M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q1 2016 was Adage Capital Partners, an estimated $6.96M sold.
Based on aggregated 13F filings for Q1 2016.